Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

99.40 -1.01 (-1.01%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 802,925
Open 96.79
Bid (Size) 98.11 (1)
Ask (Size) 100.25 (1)
Prev. Close 100.41
Today's Range 94.70 - 99.64
52wk Range 88.00 - 188.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioNTech Stock Downgraded, Analyst Reflects Concerns Over Growth and Pipeline Development
J.P. 
Via Benzinga
Lululemon To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga

Performance

YTD
-33.13%
-33.13%
1 Month
+3.78%
+3.78%
3 Month
-18.52%
-18.52%
6 Month
-8.58%
-8.58%
1 Year
-40.38%
-40.38%

More News

Read More
6 Analysts Have This to Say About BioNTech
Via Benzinga
Dell Reports Mixed Q3 Results, Joins Marvell Technology, Super Micro Computer And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is COVID-19 Vaccine Maker Moderna Stock Trading Lower Today?
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Analyst Ratings for BioNTech
Via Benzinga
Earnings Scheduled For November 6, 2023
Via Benzinga
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
Via InvestorPlace
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal
Via Talk Markets
Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review
Via Investor's Business Daily
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Via InvestorPlace
Topics Economy
Exposures Economy
Mohamed El-Erian On Yield And Oil Price Drop: Economic Boon Or Major Downturn Ahead?
Via Benzinga
BioNTech Se (BNTX) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.
Via Investor's Business Daily
Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades
Via Benzinga
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields
Via Benzinga
Topics Economy
Exposures Interest Rates
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
From BioNTech SE
Via GlobeNewswire
Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares
Via Investor's Business Daily
3 No-Brainer Stocks to Buy for Under $100 Right Now
Via The Motley Fool
7 Undervalued Stocks That Analysts Love Right Now
Via InvestorPlace
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
From Pfizer Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.